Cui Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- RNA Interference and Gene Delivery
Papers in
-
- Circular RNAs in diseases 8
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 8
- Co-authors
- Renfang Xu (6 shared papers)Xiaozhou He (5 shared papers)Xianlin Xu (3 shared papers)Wei Xia (4 shared papers)Qianqian Shi (4 shared papers)Xiaomei Li (1 shared paper)Tao Su (1 shared paper)Li Yang (1 shared paper)
- Journals
- Medicine (2 papers)BMC Cancer (2 papers)PLoS ONE (2 papers)Clinical Journal of the American Society of Nephrology (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Cui Li
45 papers receiving 653 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 311
- Molecular Biology 409
- Reproductive Medicine 31
- Ophthalmology 30
- Immunology 60
Countries citing papers authored by Cui Li
This map shows the geographic impact of Cui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui Li more than expected).
Fields of papers citing papers by Cui Li
This network shows the impact of papers produced by Cui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui Li. The network helps show where Cui Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Cui Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 84 | |
| 2 | 2016 | 74 | |
| 3 | 2013 | 52 | |
| 4 | 2008 | 47 | |
| 5 | 2019 | 38 | |
| 6 | 2020 | 26 | |
| 7 | 2011 | 25 | |
| 8 | 2017 | 24 | |
| 9 | 2013 | 24 | |
| 10 | Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer. | 2015 | 23 |
| 11 | 2019 | 22 | |
| 12 | 2011 | 21 | |
| 13 | 2012 | 20 | |
| 14 | 2019 | 17 | |
| 15 | 2020 | 14 | |
| 16 | 2021 | 13 | |
| 17 | 2020 | 13 | |
| 18 | 2020 | 12 | |
| 19 | 2022 | 10 | |
| 20 | 2021 | 9 |
About Cui Li
Cui Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Reproductive Medicine, having authored 47 papers that have together received 657 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (8 papers), MicroRNA in disease regulation (8 papers), Immunotherapy and Immune Responses (4 papers), Nanoplatforms for cancer theranostics (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Polysaccharides and Plant Cell Walls (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Cancer Research (311 citations), Molecular Biology (409 citations), Reproductive Medicine (31 citations), Ophthalmology (30 citations) and Immunology (60 citations). Cui Li has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Renfang Xu, Xiaozhou He, Xianlin Xu, Wei Xia, Qianqian Shi, Xiaomei Li, Tao Su, Li Yang, Hong Yi and Tao Ding. Their work appears in journals such as Medicine, BMC Cancer, PLoS ONE, Clinical Journal of the American Society of Nephrology and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.